BERGAMASCO, Bruno
 Distribuzione geografica
Continente #
NA - Nord America 2.884
EU - Europa 2.114
AS - Asia 1.338
SA - Sud America 35
AF - Africa 19
OC - Oceania 12
Totale 6.402
Nazione #
US - Stati Uniti d'America 2.795
CN - Cina 799
UA - Ucraina 301
SG - Singapore 285
SE - Svezia 275
DE - Germania 273
IE - Irlanda 255
FR - Francia 225
IT - Italia 215
FI - Finlandia 168
KR - Corea 138
GB - Regno Unito 123
CA - Canada 85
PL - Polonia 69
AT - Austria 59
CH - Svizzera 50
VN - Vietnam 50
BR - Brasile 27
BE - Belgio 16
GR - Grecia 16
SN - Senegal 16
IN - India 15
NL - Olanda 12
RU - Federazione Russa 12
UZ - Uzbekistan 12
AU - Australia 10
DK - Danimarca 10
HK - Hong Kong 8
BY - Bielorussia 7
NO - Norvegia 6
ES - Italia 5
JP - Giappone 5
HR - Croazia 4
PK - Pakistan 4
TW - Taiwan 4
AR - Argentina 3
ID - Indonesia 3
IR - Iran 3
MX - Messico 3
TR - Turchia 3
CL - Cile 2
IL - Israele 2
KZ - Kazakistan 2
MU - Mauritius 2
NZ - Nuova Zelanda 2
PT - Portogallo 2
AE - Emirati Arabi Uniti 1
BG - Bulgaria 1
BO - Bolivia 1
CO - Colombia 1
CY - Cipro 1
CZ - Repubblica Ceca 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GE - Georgia 1
HU - Ungheria 1
KG - Kirghizistan 1
LT - Lituania 1
LU - Lussemburgo 1
MD - Moldavia 1
ME - Montenegro 1
MN - Mongolia 1
NG - Nigeria 1
RO - Romania 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
VE - Venezuela 1
Totale 6.402
Città #
Beijing 662
Chandler 406
Dublin 254
Santa Clara 223
Singapore 209
Jacksonville 181
Villeurbanne 140
Houston 139
Dearborn 122
Ann Arbor 110
Princeton 103
Nyköping 97
Medford 95
Ashburn 85
Wilmington 74
Fairfield 72
Columbus 71
Warsaw 67
Vienna 55
Dong Ket 46
Milan 43
Boardman 41
Bern 40
Toronto 36
Boston 32
Cambridge 31
Verona 29
Woodbridge 27
Ottawa 23
Seattle 20
Lachine 18
Brussels 16
Guangzhou 15
New York 15
Redwood City 15
Turin 14
Fremont 13
Athens 12
Kunming 12
Pisa 12
Falls Church 11
Torino 11
Norwalk 10
Rome 9
Shanghai 9
Hartlepool 8
Hong Kong 8
Mountain View 8
Chongqing 7
Nanjing 7
Trento 7
Detroit 6
Edinburgh 6
Jinan 6
Redmond 6
University Park 6
Frankfurt am Main 5
Hefei 5
Council Bluffs 4
Florence 4
Fuzhou 4
Groningen 4
Helsinki 4
Munich 4
Paris 4
São Paulo 4
Zhengzhou 4
Ardabil 3
Des Moines 3
Düsseldorf 3
Hebei 3
Jakarta 3
Los Angeles 3
Montreal 3
Nanning 3
New Taipei 3
Nuremberg 3
Oslo 3
Phoenix 3
San Francisco 3
Seongnam 3
Sydney 3
Tappahannock 3
Xian 3
Zagreb 3
Almaty 2
Amherst 2
Amsterdam 2
Atlanta 2
Bari 2
Buenos Aires 2
Campinas 2
Cascina 2
Changsha 2
Chengdu 2
Dongjak-gu 2
Dresden 2
Fürth 2
Grugliasco 2
Hangzhou 2
Totale 3.930
Nome #
Transdermal apomorphine permeation from microemulsions: a new treatment in Parkinson's disease 250
Recurrent cerebrovascular ischaemic events in patients with interatrial septal abnormalities: a follow-up study 221
Nocturnal anomalous movement reduction and sleep microstructure analysis in parkinsonian patients during 1-night transdermal apomorphine treatment. 155
Pain threshold and tolerance in Alzheimer’s disease 155
Evidence for a glycidic-lipidic matrix in human neuromelanin, potentially responsible for the enhanced iron sequestering ability of substantia nigra. 144
Nuclear magnetic resonance spectroscopy characterization and iron content determination of human mesencephalic neuromelanin. 130
An analysis of peripheral type benzodiazepine receptors on blood mononuclear cells during high dose steroid treatment of multiple sclerosis. 122
Stretch reflex of quadriceps femoris and its relation to rigidity in Parkinson's disease. 112
Alpha-Synuclein protects SH-SY5Y cells from dopamine toxicity 111
Somato-sensory evoked cortical potentials in subjects with peripheral nervous lesions. 110
Restricted dissociated sensory loss in a patient with a lateral medullary syndrome: A clinical-MRI study. 104
Alzheimer’s disease neurophysiological data - a multimodal investigation 102
Deep brain stimulation of subthalamic nucleus: behavioral modifications and familiar relations 100
Antiparkinsonian therapy modifications in PD patients after STN DBS: A retrospective observational analysis 100
[Neuroendocrinologic aspects of epilepsy] 98
Proteome analysis of mesencephalic tissues: evidence for Parkinson's disease. 98
Deep brain stimulation in Parkinson's disease: comparison of pre- and post-operative neuropsychological evaluation 96
[Plasma levels of cyclic AMP and catecholamines in ischemic cerebrovascular disorders] 96
Peripheral-type benzodiazepine receptors in blood cells of anxious patients. 95
Apathy and verbal fluency in STN-stimulated PD patients 95
Apatia in pazienti con malattia di Parkinson sottoposti a DBS del nucleo subtalamico. 93
Deep brain stimulation of the subthalamic nucleus in PD: an analysis of the exclusion causes 92
Temporal changes in movement time during the switch of the stimulators in Parkinson's disease patients treated by subthalamic nucleus stimulation. 92
Expectation modulates the response to subthalamic nucleus stimulation in Parkinsonian patients. 88
Apathy and verbal fluency in STN-stimulated PD patients: An observational follow-up study 85
Utilizzazione e validità diagnostica nella sclerosi multipla dei potenziali evocati visivi e di altre attività cerebrali evocate. 85
Daytime sleepiness improvement following bilateral chronic electrical stimulation of the subthalamic nucleus in Parkinson's disease. 84
Early modification of stretch reflex in Parkinson's disease. 82
Residual substantia nigra neuromelanin in Parkinson's disease is cross-linked to alpha-synuclein. 82
Risk of cancer in patients with Guillain-Barrè syndrome (GBS). A population-based study 81
Chronic deep brain stimulation of the subthalamic nucleus for Parkinson's disease: effects on cognition, mood, anxiety and personality traits 81
“Apathy and verbal fluency in STN-stimulated PD patients”. 81
A study of 3H-PK 11,195 binding to 'peripheral-type' benzodiazepine receptors on human lymphocytes. Evidence of decreased binding in hepatic encephalopathy. 79
Quantitative EEG responses to ischaemic arm stress in migraine 79
Magnetic investigations of human mesencephalic neuromelanin 78
Deep brain stimulation of the subthalamic nucleus: anatomical, neurophysiological and outcome correlations with the effects of stimulation 78
Electroencephalographic responses to intraoperative subthalamic stimulation 77
Incidence of ALS in Italy: evidence for a uniform frequency in Western countries 76
Controlled-release transdermal apomorphine treatment for motor fluctuations in Parkinson's disease. 75
Stimolazione cerebrale profonda del nucleo subtalamico nella malattia di Parkinson: effetti sulla depressione e sull’ideazione suicidaria. 75
Complex musical hallucinosis in a professional musician with a left subcortical haemorrhage. 74
Nuclear magnetic relaxation dispersion profiles of substantia nigra pars compacta in Parkinson's disease patients are consistent with protein aggregation. 74
Deep brain stimulation of the subthalamic nucleus: Clinical effectiveness and safety 74
Effects of subcutaneous sumatriptan on quantitative EEG in migraine 73
Reduced CSF 5-HIAA levels in depressed patients with Parkinson's disease 73
Effects of deep brain stimulation of the subthalamic nucleus on sleep architecture in parkinsonian patients 71
Deep brain stimulation of the subthalamic nucleus in Parkinson's disease: long-term follow-up. 68
Visual evoked potentials and brainstem auditory evoked potentials in migraine and transient ischemic attacks. 68
Q-band EPR investigations of neuromelanin in control and Parkinson's disease patients. 67
Expression proteomics of peripheral blood lymphocytes from Parkinson's disease patients 67
Sexual well being in parkinsonian patients after deep brain stimulation of the subthalamic nucleus 66
Memory functions in relation to electroencephalographic changes in temporal-lobe epileptic patients 66
Subclinical electrophysiological alterations of phrenic nerve in chronic inflammatory demyelinating polyneuropathy. 64
Dopaminergic therapy in the follow-up of PD patients treated with STN DBS 64
Peripheral-type benzodiazepine receptors on human blood mononuclear cells are not regulated by ovarian steroids. 64
Deep brain stimulation of the subthalamic nucleus in Parkinson's disease: effects of variation in stimulation parameters. 63
High-frequency electrical stimulation of the subthalamic nucleus in Parkinson's disease: kinetic and kinematic gait analysis 61
LINEE GUIDA PER IL TRATTAMENTO DELLA MALATTIA DI PARKINSON 2002. 61
RELAZIONE TRA TARGETING ANATOMICO E NEUROFISIOLOGICO DEL NUCLEO SUBTALAMICO NELLA CHIRURGIA DELLA MALATTIA DI PARKINSON. 61
Increased intrathecal TGF-beta1, but not IL-12, IFN-gamma and IL-10 levels in Alzheimer's disease patients. 61
Treatment response and electrophysiological criteria in chronic inflammatory demyelinating polyneuropathy 61
Deep brain stimulation of the subthalamic nucleus: selection of patients and clinical results 61
EPR investigations of the iron domain in neuromelanin. 60
Studio pilota sulla percezione di malattia in pazienti con malattia di Parkinson sottoposti a DBS del nucleo subtalamico 60
Myoclonus - clinical, electrophysiological and biochemical findings 60
Neuropsychiatric therapy in the follow-up of PD patients after STN-DBS 60
La stimolazione elettrica ad alta frequenza del nucleo subtalamico nel trattamento chirurgico della malattia di Parkinson. 58
Dbs of STN for Parkinson’s disease: cognitive and behavioural outcome of 72 patients. 58
Quantitative analysis of gait in Parkinson's disease: a pilot study on the effects of bilateral sub-thalamic stimulation. 54
Hypogeusia and hearing loss in a patient with an inferior collicular infarction 53
Juvenile vertebrobasilar ischaemic stroke in a patient with Camurati-Engelmann disease 52
Higher lipoprotein (a) levels in atherothrombotic than lacunar ischemic cerebrovascular disease. 52
Isolation and 13C-NMR characterization of an insoluble proteinaceous fraction from substantia nigra of patients with Parkinson's disease. 50
Neuro-psychiatric therapy during chronic subthalamic stimulation in Parkinson's disease 49
Organizzazione di personalità in pazienti parkinsoniani sottoposti a DBS del nucleo subtalamico: uno studio attraverso il test di Rorschach 49
Motor and nonmotor symptom follow-up in parkinsonian patients after deep brain stimulation of the subthalamic nucleus 46
Expectation enhances autonomic responses to stimulation of the human subthalamic limbic region 43
Effects of bilateral subthalamic stimulation on gait kinematics and kinetics in Parkinson's disease 42
Parkinsonian patients following deep brain stimulation of the subthalamic nucleus: long term neuropsychological follow-up. 41
Peripheral-type benzodiazepine receptors in anxiety disorders. 40
Muscarinic cholinergic receptors on human lymphocytes: a comparison of 3H-QNB and 3H-NMS binding 38
Freezing and hypokinesia of gait induced by stimulation of the subthalamic region 35
Totale 6.599
Categoria #
all - tutte 22.030
article - articoli 0
book - libri 0
conference - conferenze 4.100
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26.130


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020250 0 0 0 0 0 0 0 33 70 65 68 14
2020/2021602 89 24 67 19 35 18 60 25 97 65 32 71
2021/2022701 6 16 12 64 27 24 50 30 17 78 182 195
2022/20231.177 136 82 26 132 106 323 83 68 102 40 61 18
2023/2024372 49 92 15 21 16 33 19 29 3 6 27 62
2024/2025773 9 61 28 109 369 99 42 56 0 0 0 0
Totale 6.599